Cargando…
Runx3 Restoration Regresses K-Ras-Activated Mouse Lung Cancers and Inhibits Recurrence
Oncogenic K-RAS mutations occur in approximately 25% of human lung cancers and are most frequently found in codon 12 (G12C, G12V, and G12D). Mutated K-RAS inhibitors have shown beneficial results in many patients; however, the inhibitors specifically target K-RAS(G12C) and acquired resistance is a c...
Autores principales: | Lee, Ja-Yeol, Lee, Jung-Won, Park, Tae-Geun, Han, Sang-Hyun, Yoo, Seo-Yeong, Jung, Kyoung-Mi, Kim, Da-Mi, Lee, Ok-Jun, Kim, Dohun, Chi, Xin-Zi, Kim, Eung-Gook, Lee, You-Soub, Bae, Suk-Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605764/ https://www.ncbi.nlm.nih.gov/pubmed/37887282 http://dx.doi.org/10.3390/cells12202438 |
Ejemplares similares
-
K-Ras–Activated Cells Can Develop into Lung Tumors When Runx3-Mediated Tumor Suppressor Pathways Are Abrogated
por: Lee, You-Soub, et al.
Publicado: (2020) -
Role of RUNX3 in Restriction Point Regulation
por: Lee, Jung-Won, et al.
Publicado: (2023) -
RUNX3 regulates cell cycle-dependent chromatin dynamics by functioning as a pioneer factor of the restriction-point
por: Lee, Jung-Won, et al.
Publicado: (2019) -
Runx3 regulates iron metabolism via modulation of BMP signalling
por: Kim, Hyun‐Yi, et al.
Publicado: (2021) -
Lung Cancer Staging and Associated Genetic and Epigenetic Events
por: Kim, Dohun, et al.
Publicado: (2020)